19-12676113-GATGTAA-G
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM2PM4PP3PP5_Very_Strong
The NM_001930.4(DHPS):c.912_917delTTACAT(p.Tyr305_Ile306del) variant causes a disruptive inframe deletion change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,226 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_001930.4 disruptive_inframe_deletion
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DHPS | NM_001930.4 | c.912_917delTTACAT | p.Tyr305_Ile306del | disruptive_inframe_deletion | Exon 8 of 9 | ENST00000210060.12 | NP_001921.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DHPS | ENST00000210060.12 | c.912_917delTTACAT | p.Tyr305_Ile306del | disruptive_inframe_deletion | Exon 8 of 9 | 1 | NM_001930.4 | ENSP00000210060.6 | ||
ENSG00000285589 | ENST00000648033.1 | n.*457_*462delTTACAT | non_coding_transcript_exon_variant | Exon 8 of 14 | ENSP00000498000.1 | |||||
ENSG00000285589 | ENST00000648033.1 | n.*457_*462delTTACAT | 3_prime_UTR_variant | Exon 8 of 14 | ENSP00000498000.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461226Hom.: 0 AF XY: 0.00000138 AC XY: 1AN XY: 726900
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Neurodevelopmental disorder with seizures and speech and walking impairment Pathogenic:2
- -
This variant is interpreted as Likely pathogenic for Neurodevelopmental disorder with seizures and speech and walking impairment, autosomal recessive. The following ACMG Tag(s) were applied: PM2, PM3, PS3-Moderate. -
DHPS-related disorder Pathogenic:1
The DHPS c.912_917del6 variant is predicted to result in an in-frame deletion (p.Tyr305_Ile306del). This variant has been reported in the compound heterozygous state with a second putative disease-allele in an individual with neurodevelopmental delay and seizures (Ganapathi et al. 2019. PubMed ID: 30661771). This variant has not been reported in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare in the general population. Functional analysis indicated that this variant strongly reduces DHPS enzyme activity (Ganapathi et al. 2019. PubMed ID: 30661771; Padgett et al. 2023. PubMed ID: 37333770). Taken together, this variant is classified as likely pathogenic. -
not provided Uncertain:1
The c.912_917delTTACAT variant in the DHPS gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The c.912_917delTTACAT variant causes an in-frame deletion of two amino acids, Tyrosine 305 and Isoleucine 306, denoted p.Tyr305_Ile306del. The Y305 residue is not conserved, and for the I306 residue, amino acids with similar properties to Isoleucine are tolerated across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. The c.912_917delTTACAT variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). We interpret c.912_917delTTACAT as a variant of uncertain significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at